Nasal congestion in covid-19
Pro Research Analysisby 
Searched over 200M research papers
Prevalence and Clinical Significance of Nasal Congestion in COVID-19
Nasal congestion is recognized as one of the upper respiratory tract symptoms associated with COVID-19, though its prevalence varies across studies and populations. In adults, nasal congestion has been reported in approximately 3.7% to 28.3% of COVID-19 patients, with some studies noting it as a common symptom alongside sore throat, headache, and olfactory dysfunction Lovato2020El-Anwar2021Biadsee2020. In children, nasal symptoms—including stuffy nose and nasal congestion—are observed in about 22% of cases, making them a notable but not dominant feature in pediatric COVID-19 presentations .
Nasal Congestion Compared to Other COVID-19 Symptoms
While fever, cough, and fatigue remain the most frequent symptoms of COVID-19, nasal congestion is less common but still significant, especially when considered with other ENT (ear, nose, and throat) manifestations such as sore throat, rhinorrhea, and loss of smell or taste Lovato2020El-Anwar2021Krajewska2020+2 MORE. Notably, nasal congestion and other upper respiratory symptoms are more frequently observed in younger patients and can sometimes appear before more severe symptoms or even before laboratory confirmation of infection .
Pathophysiology and Cytological Findings in COVID-19 Nasal Congestion
Unlike other viral infections that often cause pronounced nasal symptoms and visible mucosal swelling, COVID-19 tends to produce only mild nasal inflammation. Cytological studies show that COVID-19 patients with nasal congestion typically exhibit minimal cellular damage in the nasal mucosa, with few neutrophils and only slight signs of cellular distress. This mild cytopathological profile aligns with the generally mild nasal symptoms reported by patients . The virus appears to have a site-specific effect on olfactory cells, which may explain the frequent occurrence of smell impairment alongside mild nasal congestion .
Nasal Congestion as a Risk Factor and Clinical Indicator
Nasal congestion, especially when accompanied by a runny nose, has been identified as a risk factor for COVID-19 reinfection, particularly in older adults and those with low lymphocyte counts . This suggests that nasal symptoms may have prognostic value in certain patient populations and should be considered in clinical assessments.
Treatment Approaches for COVID-19-Related Nasal Congestion
In some regions, such as China, acupuncture has been explored as a treatment for COVID-19-induced nasal congestion. Ongoing systematic reviews aim to evaluate the efficacy and safety of such interventions, which may inform future clinical guidelines .
Conclusion
Nasal congestion is a recognized but less common symptom of COVID-19, often occurring alongside other upper respiratory and olfactory symptoms. Its presence can aid in the early identification of COVID-19, especially in younger patients and children. While generally mild, nasal congestion may have clinical significance in predicting reinfection risk and guiding patient management. Further research is needed to clarify its pathophysiology and to establish evidence-based treatment strategies.
Sources and full results
Most relevant research papers on this topic